Guided self-help for depression adapted for autistic adults: a multi-centre randomised controlled phase 3 trial (ADEPT-2).

Introduction Autistic people are disproportionately affected by depression and access recommended first line treatments such as Guided Self-Help (GSH)) which has not been developed to meet their needs. This study aims to test the effectiveness of autism adapted GSH for depression compared to treatment as usual. Methods A two parallel group multi-centre randomised controlled trial investigated the effectiveness of GSH adapted for autism. The RCT was registered on 09th August 2022 (ISRCTN: 17547011). Adults, ≥18 years, with a confirmed autism diagnosis and symptoms of depression (PHQ-9 ≥ 10) recruited from community settings were randomised to GSH or Treatment as Usual (TAU). Adapted GSH comprised psychoeducation and behavioural activation supported by nine meetings with a coach. Beck Depression Inventory (BDI-II) scores at 16-weeks post-randomisation were analysed on an intention to treat basis. Additional measures at 16-weeks captured anxiety, well-being and service use with follow up at 32- and 52-weeks. Results Participants (n=266) were randomised to GSH (n=132) or TAU (n=134). Of participants randomised to GSH, 110 (81%) completed the minimum 6 session dose, five did not begin the intervention and 28 discontinued. Estimated between group mean difference in BDI-II scores at 16 weeks was -5.05 (95% CI: -7.85 to -2.24, P<0.001, d=0.47) in favour of GSH, with the difference sustained at 52-weeks. Conclusion The intervention named Autism Affirming Accompanied Self-Help for depression (AASH-DEP) needs to be rolled-out so clinicians and autistic people can be confident to access effective treatment for depression adapted for autism.

Authors

Publication Details

Journal
PubMed
Published
2026-11-13
DOI
https://doi.org/10.1159/pps/aemag025
Primary Topic
Digital Mental Health Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Guided self-help for depression adapted for autistic adults: a multi-centre randomised controlled phase 3 trial (ADEPT-2).

Dheeraj Rai, Alba X. Realpe, Barry Ingham, Joanna Thorn et al.
PubMed
Digital Mental Health Interventions
article

Guided self-help for depression adapted for autistic adults: a multi-centre randomised controlled phase 3 trial (ADEPT-2).

Dheeraj Rai, Alba X. Realpe, Barry Ingham, Joanna Thorn, Jeremy Horwood, Kate Cooper, Leonora Cotton, Vicky Jervis, Rona Aldridge, Aikaterini Georgakopoulou, David Kessler, Ailsa Russell, Dave Dagnan, Kirsty Garfield, Mannat Chopra, Alison Cape, Nicola Wiles, Peter E Langdon, Maximiliano Vazquez-Morales, Chris Metcalfe
article en

Abstract

Introduction Autistic people are disproportionately affected by depression and access recommended first line treatments such as Guided Self-Help (GSH)) which has not been developed to meet their needs. This study aims to test the effectiveness of autism adapted GSH for depression compared to treatment as usual. Methods A two parallel group multi-centre randomised controlled trial investigated the effectiveness of GSH adapted for autism. The RCT was registered on 09th August 2022 (ISRCTN: 17547011). Adults, ≥18 years, with a confirmed autism diagnosis and symptoms of depression (PHQ-9 ≥ 10) recruited from community settings were randomised to GSH or Treatment as Usual (TAU). Adapted GSH comprised psychoeducation and behavioural activation supported by nine meetings with a coach. Beck Depression Inventory (BDI-II) scores at 16-weeks post-randomisation were analysed on an intention to treat basis. Additional measures at 16-weeks captured anxiety, well-being and service use with follow up at 32- and 52-weeks. Results Participants (n=266) were randomised to GSH (n=132) or TAU (n=134). Of participants randomised to GSH, 110 (81%) completed the minimum 6 session dose, five did not begin the intervention and 28 discontinued. Estimated between group mean difference in BDI-II scores at 16 weeks was -5.05 (95% CI: -7.85 to -2.24, P<0.001, d=0.47) in favour of GSH, with the difference sustained at 52-weeks. Conclusion The intervention named Autism Affirming Accompanied Self-Help for depression (AASH-DEP) needs to be rolled-out so clinicians and autistic people can be confident to access effective treatment for depression adapted for autism.

PubMed
Digital Mental Health Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon